A recent survey from State Street Investment Management* finds that 77 per cent of asset owners in EMEA that responded are integrating nature and biodiversity into their investment strategies. One ...
Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...
The path from promising scientific insight to an Investigational New Drug (IND) application is both exhilarating and unforgiving. Regardless of how breakthrough the science may be, success depends on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results